Abcellera Biologics Inc
Change company Symbol lookup
Select an option...
ABCL Abcellera Biologics Inc
UVV Universal Corp
LNC Lincoln National Corp
FMCCG Federal Home Loan Mortgage Corp
CSAN Cosan SA
SAIC Science Applications International Corp
MUR Murphy Oil Corp
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
CODI Compass Diversified Holdings
MDRRP Medalist Diversified Reit Inc
Go

Health Care : Life Sciences Tools & Services | Mid Cap Growth
Based in Canada
Company profile

AbCellera Biologics Inc. (AbCellera) is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.

Closing Price
$7.77
Day's Change
-0.04 (-0.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.05
Day's Low
7.62
Volume
(Below Average)
Volume:
2,161,898

10-day average volume:
2,526,885
2,161,898
  • Prev Close
    7.81
  • Today's Open
    8.05
  • Day's Range
    7.62-8.05
  • Avg Vol (10-day)
    2.5M
  • Last (time)
    4:00p ET 01/27/22
  • Last (size)
    25
  • 52-Wk Range
    7.42 - 55.22
    LowHigh
  • (01/29/21 - 01/24/22)
    4.72%
  • 81.8%
  • Market Cap
    2.2B
  • Shares Outstanding
    281.6M
  • 0.71
  • 11.71x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 43.43
  • (% of float 12/31/21)
    5.35

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.